MedPath

NORMOSOL-R & 5% DEXTROSE

NORMOSOL-R & 5% DEXTROSE

Dormant
DIN Number

00039640

Drug Class

Human

Market Date

Dec 31, 1965

Company
HC

ICU Medical Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00039640
AIG Number0600060004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BB02 ELECTROLYTES WITH CARBOHYDRATES
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (6)

DEXTROSEActive
Strength: 5 G / 100 ML
Monograph: DEXTROSE
MAGNESIUM CHLORIDEActive
Strength: 0.014 G / 100 ML
Monograph: MAGNESIUM CHLORIDE
POTASSIUM CHLORIDEActive
Strength: 0.037 G / 100 ML
Monograph: POTASSIUM CHLORIDE
SODIUM ACETATEActive
Strength: 0.222 G / 100 ML
Monograph: SODIUM ACETATE
SODIUM CHLORIDEActive
Strength: 0.526 G / 100 ML
Monograph: SODIUM CHLORIDE
SODIUM GLUCONATEActive
Strength: 0.502 G / 100 ML
Monograph: SODIUM GLUCONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.